Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
about
CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assaysCross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymersHuman cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipientsDetection of human cytomegalovirus pp67 late gene transcripts in cerebrospinal fluid of human immunodeficiency virus type 1-infected patients by nucleic acid sequence-based amplification.Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assaysDetection of Mycoplasma pneumoniae in spiked clinical samples by nucleic acid sequence-based amplificationPrevention of cytomegalovirus disease in recipients of allogeneic stem cell transplantsDiagnostic value of reverse transcription-PCR for detection of cytomegalovirus pp67 in samples from solid-organ transplant recipients.Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification.Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.
P2860
Q24799339-84150AF1-8577-473F-9905-D5F6633AD68EQ28367797-CDBF0C0F-EEFF-4343-840F-DAD946C470D0Q33966910-33A1E552-313E-4500-9D84-8AC38DF7555FQ33966960-E440D78B-E30F-4FCF-9AFD-9D9DF10240E1Q34102747-C0946185-B571-406E-8994-C79380AFF22DQ34202805-F285034B-3EC6-457E-B1F6-FC50ADA828B0Q34453887-69626569-AFC9-47CE-84E1-D82059833F7DQ35558815-5E404803-18FE-4ED2-AC3E-690A78C10235Q38475498-E31DD81C-6815-4D54-88BD-7CACCC96EAEFQ39461995-652AA6B9-9D5E-4911-8D0A-6C33A46F6658Q39462509-D09F8919-0AB6-4B11-B55A-F7661B7DE630Q39462962-79946F42-BB29-4AF5-A047-2317FF6A1122Q39591457-2112A0CB-F04E-43E5-82D4-A811EBE5BC3C
P2860
Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Clinical significance of expre ...... sequence-based amplification.
@en
type
label
Clinical significance of expre ...... sequence-based amplification.
@en
prefLabel
Clinical significance of expre ...... sequence-based amplification.
@en
P2093
P2860
P1476
Clinical significance of expre ...... d sequence-based amplification
@en
P2093
P2860
P304
P407
P577
1999-04-01T00:00:00Z